Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Peter Kubisz"'
Autor:
Monika Brunclikova, Jela Ivankova, Maria Skerenova, Tomas Simurda, Lucia Stanciakova, Ingrid Skornova, Miroslava Sterankova, Jana Zolkova, Miroslava Dobrotova, Pavol Holly, Peter Kubisz, Jan Stasko
Publikováno v:
Acta Medica Martiniana, Vol 22, Iss 1, Pp 34-44 (2022)
Introduction: Inherited platelet hyperaggregability, so called “Sticky platelet syndrome” (SPS), is a prothrombotic platelet disorder. The syndrome contributes more often to arterial than venous thrombosis. The most common localization of arteria
Externí odkaz:
https://doaj.org/article/81cad9474a4041239c0c6896498e153f
Autor:
Lucia Stanciakova MD, PhD, Miroslava Dobrotova MD, PhD, Pavol Holly MD, PhD, Jana Zolkova MSc, PhD, Lubica Vadelova MSc, PhD, Ingrid Skornova MA, PhD, Jela Ivankova MSc, Matej Samos MD, PhD, Tomas Bolek MD, PhD, Marian Grendar MSc, PhD, Jan Danko MD, PhD, Peter Kubisz MD, DSc, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during preg
Externí odkaz:
https://doaj.org/article/1446eff435f34e45a8e508419e73fd28
Autor:
Ingrid Škorňová, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ľubica Vádelová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents h
Externí odkaz:
https://doaj.org/article/b80471fb545746388efc3792ab8b5bc4
Autor:
Tomas Simurda, Rosanna Asselta, Jana Zolkova, Monika Brunclikova, Miroslava Dobrotova, Zuzana Kolkova, Dusan Loderer, Ingrid Skornova, Jan Hudecek, Zora Lasabova, Jan Stasko, Peter Kubisz
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2140 (2021)
Congenital fibrinogen disorders are rare pathologies of the hemostasis, comprising quantitative (afibrinogenemia, hypofibrinogenemia) and qualitative (dysfibrinogenemia and hypodysfibrinogenemia) disorders. The clinical phenotype is highly heterogene
Externí odkaz:
https://doaj.org/article/1b2962a9071f4dddb96c55543b50554b
Autor:
Ingrid Skornova, Tomas Simurda, Jan Stasko, Jana Zolkova, Juraj Sokol, Pavol Holly, Miroslava Dobrotova, Ivana Plamenova, Jan Hudecek, Monika Brunclikova, Alena Stryckova, Peter Kubisz
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2153 (2021)
von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and/or deficiency of the plasma protein von Willebrand factor (VWF). Laboratory testing for VWF-related disorders re
Externí odkaz:
https://doaj.org/article/044a479f87c64ae6989a805ed7e053f0
Autor:
Lucia Stanciakova, Miroslava Dobrotova, Pavol Holly, Jana Zolkova, Lubica Vadelova, Ingrid Skornova, Jela Ivankova, Tomas Bolek, Matej Samos, Marian Grendar, Jan Danko, Peter Kubisz, Jan Stasko
Publikováno v:
Diagnostics, Vol 11, Iss 5, p 828 (2021)
Thromboprophylaxis with low-molecular-weight heparin (LMWH) for patients with a history of venous thromboembolism (VTE) is suggested. Rotational thromboelastometry (ROTEM®) represents an innovative point-of-care method enabling the complex and quick
Externí odkaz:
https://doaj.org/article/d3b778e32d9946dc82b545930afbb383
Autor:
Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical cour
Externí odkaz:
https://doaj.org/article/65a50962082648c3a0445471b3c7e0aa
Autor:
Matej Samoš, Ingrid Škorňová, Tomáš Bolek, Lucia Stančiaková, Barbora Korpallová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Publikováno v:
Diagnostics, Vol 11, Iss 1, p 143 (2021)
Platelets play crucial role in acute vascular atherosclerotic diseases, including myocardial infarction and stroke. Additionally, platelet aggregation is a key target of antiplatelet agents, forming the keystone of pharmacotherapy of various atherosc
Externí odkaz:
https://doaj.org/article/32c16b71f4a84d06983c2229c742443b
Autor:
Tomas Simurda, Rui Vilar, Jana Zolkova, Eliska Ceznerova, Zuzana Kolkova, Dusan Loderer, Marguerite Neerman-Arbez, Alessandro Casini, Monika Brunclikova, Ingrid Skornova, Miroslava Dobrotova, Marian Grendar, Jan Stasko, Peter Kubisz
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 605 (2020)
Congenital hypofibrinogenemia is a rare bleeding disorder characterized by a proportional decrease of functional and antigenic fibrinogen levels. Hypofibrinogenemia can be considered the phenotypic expression of heterozygous loss of function mutation
Externí odkaz:
https://doaj.org/article/ba8b9f1b146c40b690bf7f4ed9c97dc4
Autor:
Tomas Simurda, Monika Brunclikova, Rosanna Asselta, Sonia Caccia, Jana Zolkova, Zuzana Kolkova, Dusan Loderer, Ingrid Skornova, Jan Hudecek, Zora Lasabova, Jan Stasko, Peter Kubisz
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 13, p 4616 (2020)
Fibrinogen is a hexameric plasmatic glycoprotein composed of pairs of three chains (Aα, Bβ, and γ), which play an essential role in hemostasis. Conversion of fibrinogen to insoluble polymer fibrin gives structural stability, strength, and adhesive
Externí odkaz:
https://doaj.org/article/387723c270a74da99a2b53ab44313bbf